WILLIAMS TIMOTHY (SVP & General Counsel) sold 13.9% of their position (16.74K shares) of VANDA PHARMACEUTICALS INC. on the open market
Open‑market sale worth $104.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/6/2023ACC: 0001209191-23-016464
Officer· SVP & General Counsel
Since Aug 2018
-16.74K
Net shares
Net seller
$104.6K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
16.74K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−8.44K
Price / share
$6.24
Trade value
$52.68K
% of position
7.0%
3/2/2023
120.25K→111.81K
Common Stock
Direct
Shares
−8.30K
Price / share
$6.25
Trade value
$51.89K
% of position
7.4%
3/3/2023
111.81K→103.51K
Total
Net shares
−16.74K
Net value
-$104.57K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/2/2023 | S · Sale | −8.44K | $6.24 | $52.68K | 7.0% | 120.25K | 111.81K |
| Common Stock Direct | 3/3/2023 | S · Sale | −8.30K | $6.25 | $51.89K | 7.4% | 111.81K | 103.51K |
| Total | −16.74K | -$104.57K | ||||||
Derivative Transactions0
No derivative transactions reported